Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Gurbel

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Mild myocardial stunning affects platelet aggregation and certain hemostatic factors in swineV L Serebruany, V V Yurovsky, P A Gurbel
Pharmacological Research|June 8, 2001
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitorsV L Serebruany, P A Gurbel, C M O'Connor
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1996
Serial changes of natural antithrombotics during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, W R Herzog, P A Gurbel
Journal of Thrombosis and Thrombolysis|August 18, 2000
Soluble P-selectin is not a surrogate marker for platelet P-selectin: evidence from a multicenter chest pain study groupP A Gurbel, D J Kereiakes, V L Serebruany
Life Sciences|October 26, 1999
Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarctionV L Serebruany, V V Yurovsky, P A Gurbel
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 1, 1997
Serial changes of the plasma prostanoids during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, W R Herzog, P A Gurbel
Scandinavian Cardiovascular Journal : SCJ|May 18, 2000
Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarctionP A Gurbel, D J Kereiakes, D Atar, et al.
Thrombosis and Haemostasis|December 21, 2012
Evaluating the clinical usefulness of platelet function testing: considerations for the proper application and interpretation of performance measuresJ R Dahlen, M J Price, H Parise, et al.
Pharmacological Research|August 6, 1999
Clopidogrel: the future choice for preventing platelet activation during coronary stenting?P A Gurbel, C M O'Connor, C C Cummings, et al.
Thrombosis Research|November 30, 1999
The flow cytometer model markedly affects measurement of ex vivo whole blood platelet-bound P-selectin expression in patients with chest pain: are we comparing apples with orangesV L Serebruany, D J Kereiakes, M R Dalesandro, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Mild myocardial stunning affects platelet aggregation and certain hemostatic factors in swineV L Serebruany, V V Yurovsky, P A Gurbel
Pharmacological Research|June 8, 2001
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitorsV L Serebruany, P A Gurbel, C M O'Connor
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1996
Serial changes of natural antithrombotics during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, W R Herzog, P A Gurbel
Journal of Thrombosis and Thrombolysis|August 18, 2000
Soluble P-selectin is not a surrogate marker for platelet P-selectin: evidence from a multicenter chest pain study groupP A Gurbel, D J Kereiakes, V L Serebruany
Life Sciences|October 26, 1999
Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarctionV L Serebruany, V V Yurovsky, P A Gurbel
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 1, 1997
Serial changes of the plasma prostanoids during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, W R Herzog, P A Gurbel
Scandinavian Cardiovascular Journal : SCJ|May 18, 2000
Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarctionP A Gurbel, D J Kereiakes, D Atar, et al.
Thrombosis and Haemostasis|December 21, 2012
Evaluating the clinical usefulness of platelet function testing: considerations for the proper application and interpretation of performance measuresJ R Dahlen, M J Price, H Parise, et al.
Pharmacological Research|August 6, 1999
Clopidogrel: the future choice for preventing platelet activation during coronary stenting?P A Gurbel, C M O'Connor, C C Cummings, et al.
Thrombosis Research|November 30, 1999
The flow cytometer model markedly affects measurement of ex vivo whole blood platelet-bound P-selectin expression in patients with chest pain: are we comparing apples with orangesV L Serebruany, D J Kereiakes, M R Dalesandro, et al.
Pageof 8